CD10-positive myxofibrosarcomas: A pitfall in the differential diagnosis of atypical fibroxanthoma

Journal of Cutaneous Pathology

Volumn 37, Issue 7, 2010, Pages 737-743

  Clarke, Loren E ^a   Frauenhoffer, Elizabeth ^a   Fox, Edward ^a   Neves, Rogerio ^a   Bruggeman, Richard D ^a   Helm, Klaus F ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; DERMATOFIBROMA; DIFFERENTIAL DIAGNOSIS; FIBROSARCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; SKIN TUMOR; SOFT TISSUE TUMOR; TISSUE MICROARRAY;

DIAGNOSIS, DIFFERENTIAL; FIBROSARCOMA; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; NEPRILYSIN; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952573382     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01532.x     Document Type: Article

References (15)

1. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000 113 : 374.
2. Kanitakis J, Bourchany D, Claudy A. Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin. Anticancer Res 2000 20 : 3539.
3. de Feraudy S, Mar N, McCalmont TH. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol 2008 32 : 1111.
4. Weedon D, Williamson R, Mirza B. CD10, a useful marker for atypical fibroxanthomas. Am J Dermatopathol 2005 27 : 181.
5. Hall JM, Saenger JS, Fadare O. Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas. Int J Clin Exp Pathol 2008 1 : 524.
6. Hultgren TL, DiMaio DJ. Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol 2007 34 : 415.
7. Bilalovic N, Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol 2004 17 : 1251.
8. Kanitakis J, Narvaez D, Claudy A. Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res 2002 12 : 241.
9. Carrel S, Zografos L, Schreyer M, Rimoldi D. Expression of CALLA/CD10 on human melanoma cells. Melanoma Res 1993 3 : 319.
10. Mentzel, van Den Berg E, Molenaar WM. Myxofibrosarcoma World Health Organization Classification of tumors. 2002, 102.
11. Fujimura T, Okuyama R, Terui T, et al. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases. J Cutan Pathol 2005 32 : 512.
12. Clarke LE, Zhang PJ, Crawford GH, Elenitsas R. Myxofibrosarcoma in the skin. J Cutan Pathol 2008 35 : 935.
13. Mansoor A, White CR, Jr. Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms. Am J Dermatopathol 2003 25 : 281.
14. Mitsuhashi T, Barr RJ, Machtinger LA, Cassarino DS. Primary cutaneous myxofibrosarcoma mimicking pleomorphic hyalinizing angiectatic tumor (PHAT): a potential diagnostic pitfall. Am J Dermatopathol 2005 27 : 322.
15. Patton A, Page R, Googe PB, King R. Myxoid atypical fibroxanthoma: a previously undescribed variant. J Cutan Pathol 2009 36 : 1177.